Can venous ProBNP levels predict placenta accreta?. (16th December 2016)

• Record Type: Journal Article
• Authors: Ersoy, Ali Ozgur; Oztas, Efser; Ozler, Sibel; Ersoy, Ebru; Erkenekli, Kudret; Uygur, Dilek; Caglar, Ali Turhan; Danisman, Nuri
• Is Part Of: Journal of maternal-fetal & neonatal medicine. Volume 29:Number 24(2016)
• Page Start: 4020
• Page End: 4024
• Publication Date: 2016-12-16
• Subjects: Cardiac biomarkers -- placenta accreta -- placenta previa -- pro-brain natriuretic peptide -- Troponin I; Obstetrics -- Periodicals; Perinatology -- Periodicals; Infants (Newborn) -- Diseases -- Periodicals; Neonatology -- Periodicals; 618.2
• DOI: 10.3109/14767058.2016.1152576
• Languages: English
• ISSNs: 1476-7058

Abstract

Abstract: Aim : Placenta previa (PP) is a potential life-threatening pregnancy complication. Pro-brain natriuretic peptide (ProBNP), creatine kinase (CK), cardiac form of CK (CK-MB) and Troponin I are circulatory biomarkers related to cardiac functions. We aimed to determine whether these biomarkers are related to PP and placenta accreta. Methods : In this case-control study, fifty-four pregnant women who attended our tertiary care center for perinatology with the diagnosis of PP totalis, and of them, 14 patients with placenta accreta were recruited as the study groups. Forty-six uncomplicated control patients who were matched for age, BMI were also included. Maternal venous ProBNP, CK, CK-MB and Troponin I levels were compared between the three groups. Results : Obstetric history characteristics were comparable among groups, generally. CK and CK-MB levels were similar among three groups. Troponin I levels in the previa and accreta groups were significantly higher than the controls. ProBNP levels in the accreta group were significantly higher than other two groups. The multivariate regression model revealed that ProBNP could predict placental adhesion anomalies. Conclusions : Troponin I and ProBNP levels in PP cases were higher than controls and ProBNP could predict placenta accreta.